Global Fibromyalgia Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class (Anticonvulsants, Antidepressants, Muscle Relaxants and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

The Global Fibromyalgia Treatment Market size is expected to reach $4 billion by 2030, rising at a market growth of 4.4% CAGR during the forecast period.

Muscle Relaxants are widely utilized by people to ease muscle stiffness or spasms and help in relaxing painful knots. As road accidents are increasing, the usage of muscle relaxant is increasing. Therefore, Muscle relaxants accounted for $202.3 million revenue in 2022. Road traffic accidents kill approximately 1.3 million people annually and injure between 20 and 50 million others, as stated by the WHO report. Over fifty percent of road traffic deaths and injuries involve vulnerable road users, such as pedestrians, motorcyclists, cyclists, and passengers. Children and young adults aged 5 to 29 are disproportionately susceptible to road traffic injuries.

Among people of this age, it is the most common cause of death. Males under 25 are more likely than females to be involved in traffic incidents. According to statistics, males account for 73% of the traffic fatalities in this age group. 93% of road traffic fatalities occur in low- and middle-income countries, increasing road traffic injury rates in developing nations. Consequently, the rise in road accidents due to various factors is anticipated to increase the cases of fibromyalgia, which will raise the need for fibromyalgia treatment, thereby driving market expansion. Some of the factors impacting the market are research for novel drugs and possible uses of combination therapy, Co-relation between lupus and fibromyalgia, and non-drug alternative.

Chronic fibromyalgia substantially limits patients' ability to engage in typical social and professional activities and makes maintaining relationships with friends, family, and coworkers difficult. The full spectrum of pain, tiredness, sleep disturbances, and depression symptoms cannot be fully addressed by any available medicines. The growing need for better and more effective treatment options for FM will spur pharmaceutical companies to continue their research and development efforts, driving the market. Lupus is a common (chronic) autoimmune disorder that can be debilitating and has the potential to affect a variety of body systems. Lupus is developed when the immune system, which typically aids in defending the body against infection and disease, targets its tissues. As a result, it is anticipated that their prevalence will rise along with the number of lupus cases, fueling demand for fibromyalgia treatment options and fueling market expansion.

However, Fibromyalgia can be managed with non-drug alternatives with many benefits while incurring no side effects. One such alternative is stress management. This works by creating a strategy to prevent or reduce overexertion and emotional tension and allowing oneself daily relaxation time. This is expected to hamper the market growth in the projected period. Fibromyalgia is reportedly widespread among those who have recovered from COVID-19, according to a study from the National Center for Biotechnology Information (NCBI). This data suggests that fibromyalgia may be more common among those who have had COVID-19, increasing the need for treatment after the pandemic. Hence, the pandemic caused the market to decline, but later, the market started to recover due to the growing number of FM cases.

Distribution Channel Outlook

On the basis of distribution channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies and online providers. The drug stores & retail pharmacies segment witnessed the largest revenue share in the market in 2022. The segment growth is due to the presence of drug stores and retail pharmacies in multiple locations in diverse neighborhoods and communities, which are extensively accessible to the general public. This ubiquitous presence guarantees easy access to drugs and treatments for those with fibromyalgia.

Drug Class Outlook

Based on drug class, the market is segmented into antidepressants, anticonvulsants, muscle relaxants and others. The antidepressants segment acquired a substantial revenue share in the market in 2022. This is because there are several antidepressant choices accessible for fibromyalgia patients. Multiple antidepressants are readily available, allowing for greater prescribing flexibility and a greater chance that each patient will receive the right treatment. This market's expansion is also anticipated to be aided by the availability of generic versions of antidepressants approved for use in fibromyalgia patients.

Fibromyalgia Treatment Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 2.9 Billion
Market size forecast in 2030	USD 4 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2030
Revenue Growth Rate	CAGR of 4.4% from 2023 to 2030
Number of Pages	173
Number of Table	270
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Drug Class, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Research for novel drugs and possible uses of combination therapy Co-relation between lupus and fibromyalgia
Restraints	Non-drug alternative

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the market in 2022. This is due to several variables, including increased fibromyalgia prevalence, new treatment choices, and supporting healthcare infrastructure. A vital healthcare infrastructure, high purchasing power, and increased acceptance of fibromyalgia drugs are anticipated to fuel market expansion. The market in this region is also driven by numerous significant players and developments in manufacturing technology these businesses use to manufacture effective goods.

Free Valuable Insights: Global Fibromyalgia Treatment Market size to reach USD 4 Billion by 2030

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Novartis AG, Eli Lilly And Company, Amneal Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd., Zydus Lifesciences Ltd., Lupin Limited, Abbott Laboratories, Viatris, Inc., and Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Drug Class

• Anticonvulsants
• Antidepressants
• Muscle Relaxants
• Others

By Distribution Channel

• Drug stores & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Novartis AG
• Eli Lilly And Company
• Amneal Pharmaceuticals, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Zydus Lifesciences Ltd.
• Lupin Limited
• Abbott Laboratories
• Viatris, Inc.
• Sun Pharmaceutical Industries Ltd.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Fibromyalgia Treatment Market, by Drug Class
1.4.2 Global Fibromyalgia Treatment Market, by Distribution Channel
1.4.3 Global Fibromyalgia Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Fibromyalgia Treatment Market by Drug Class
3.1 Global Anticonvulsants Market by Region
3.2 Global Antidepressants Market by Region
3.3 Global Muscle Relaxants Market by Region
3.4 Global Others Market by Region

Chapter 4. Global Fibromyalgia Treatment Market by Distribution Channel
4.1 Global Drug stores & Retail Pharmacies Market by Region
4.2 Global Hospital Pharmacies Market by Region
4.3 Global Online Providers Market by Region

Chapter 5. Global Fibromyalgia Treatment Market by Region
5.1 North America Fibromyalgia Treatment Market
5.1.1 North America Fibromyalgia Treatment Market by Drug Class
5.1.1.1 North America Anticonvulsants Market by Country
5.1.1.2 North America Antidepressants Market by Country
5.1.1.3 North America Muscle Relaxants Market by Country
5.1.1.4 North America Others Market by Country
5.1.2 North America Fibromyalgia Treatment Market by Distribution Channel
5.1.2.1 North America Drug stores & Retail Pharmacies Market by Country
5.1.2.2 North America Hospital Pharmacies Market by Country
5.1.2.3 North America Online Providers Market by Country
5.1.3 North America Fibromyalgia Treatment Market by Country
5.1.3.1 US Fibromyalgia Treatment Market
5.1.3.1.1 US Fibromyalgia Treatment Market by Drug Class
5.1.3.1.2 US Fibromyalgia Treatment Market by Distribution Channel
5.1.3.2 Canada Fibromyalgia Treatment Market
5.1.3.2.1 Canada Fibromyalgia Treatment Market by Drug Class
5.1.3.2.2 Canada Fibromyalgia Treatment Market by Distribution Channel
5.1.3.3 Mexico Fibromyalgia Treatment Market
5.1.3.3.1 Mexico Fibromyalgia Treatment Market by Drug Class
5.1.3.3.2 Mexico Fibromyalgia Treatment Market by Distribution Channel
5.1.3.4 Rest of North America Fibromyalgia Treatment Market
5.1.3.4.1 Rest of North America Fibromyalgia Treatment Market by Drug Class
5.1.3.4.2 Rest of North America Fibromyalgia Treatment Market by Distribution Channel
5.2 Europe Fibromyalgia Treatment Market
5.2.1 Europe Fibromyalgia Treatment Market by Drug Class
5.2.1.1 Europe Anticonvulsants Market by Country
5.2.1.2 Europe Antidepressants Market by Country
5.2.1.3 Europe Muscle Relaxants Market by Country
5.2.1.4 Europe Others Market by Country
5.2.2 Europe Fibromyalgia Treatment Market by Distribution Channel
5.2.2.1 Europe Drug stores & Retail Pharmacies Market by Country
5.2.2.2 Europe Hospital Pharmacies Market by Country
5.2.2.3 Europe Online Providers Market by Country
5.2.3 Europe Fibromyalgia Treatment Market by Country
5.2.3.1 Germany Fibromyalgia Treatment Market
5.2.3.1.1 Germany Fibromyalgia Treatment Market by Drug Class
5.2.3.1.2 Germany Fibromyalgia Treatment Market by Distribution Channel
5.2.3.2 UK Fibromyalgia Treatment Market
5.2.3.2.1 UK Fibromyalgia Treatment Market by Drug Class
5.2.3.2.2 UK Fibromyalgia Treatment Market by Distribution Channel
5.2.3.3 France Fibromyalgia Treatment Market
5.2.3.3.1 France Fibromyalgia Treatment Market by Drug Class
5.2.3.3.2 France Fibromyalgia Treatment Market by Distribution Channel
5.2.3.4 Russia Fibromyalgia Treatment Market
5.2.3.4.1 Russia Fibromyalgia Treatment Market by Drug Class
5.2.3.4.2 Russia Fibromyalgia Treatment Market by Distribution Channel
5.2.3.5 Spain Fibromyalgia Treatment Market
5.2.3.5.1 Spain Fibromyalgia Treatment Market by Drug Class
5.2.3.5.2 Spain Fibromyalgia Treatment Market by Distribution Channel
5.2.3.6 Italy Fibromyalgia Treatment Market
5.2.3.6.1 Italy Fibromyalgia Treatment Market by Drug Class
5.2.3.6.2 Italy Fibromyalgia Treatment Market by Distribution Channel
5.2.3.7 Rest of Europe Fibromyalgia Treatment Market
5.2.3.7.1 Rest of Europe Fibromyalgia Treatment Market by Drug Class
5.2.3.7.2 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel
5.3 Asia Pacific Fibromyalgia Treatment Market
5.3.1 Asia Pacific Fibromyalgia Treatment Market by Drug Class
5.3.1.1 Asia Pacific Anticonvulsants Market by Country
5.3.1.2 Asia Pacific Antidepressants Market by Country
5.3.1.3 Asia Pacific Muscle Relaxants Market by Country
5.3.1.4 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
5.3.2.1 Asia Pacific Drug stores & Retail Pharmacies Market by Country
5.3.2.2 Asia Pacific Hospital Pharmacies Market by Country
5.3.2.3 Asia Pacific Online Providers Market by Country
5.3.3 Asia Pacific Fibromyalgia Treatment Market by Country
5.3.3.1 China Fibromyalgia Treatment Market
5.3.3.1.1 China Fibromyalgia Treatment Market by Drug Class
5.3.3.1.2 China Fibromyalgia Treatment Market by Distribution Channel
5.3.3.2 Japan Fibromyalgia Treatment Market
5.3.3.2.1 Japan Fibromyalgia Treatment Market by Drug Class
5.3.3.2.2 Japan Fibromyalgia Treatment Market by Distribution Channel
5.3.3.3 India Fibromyalgia Treatment Market
5.3.3.3.1 India Fibromyalgia Treatment Market by Drug Class
5.3.3.3.2 India Fibromyalgia Treatment Market by Distribution Channel
5.3.3.4 South Korea Fibromyalgia Treatment Market
5.3.3.4.1 South Korea Fibromyalgia Treatment Market by Drug Class
5.3.3.4.2 South Korea Fibromyalgia Treatment Market by Distribution Channel
5.3.3.5 Singapore Fibromyalgia Treatment Market
5.3.3.5.1 Singapore Fibromyalgia Treatment Market by Drug Class
5.3.3.5.2 Singapore Fibromyalgia Treatment Market by Distribution Channel
5.3.3.6 Malaysia Fibromyalgia Treatment Market
5.3.3.6.1 Malaysia Fibromyalgia Treatment Market by Drug Class
5.3.3.6.2 Malaysia Fibromyalgia Treatment Market by Distribution Channel
5.3.3.7 Rest of Asia Pacific Fibromyalgia Treatment Market
5.3.3.7.1 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class
5.3.3.7.2 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
5.4 LAMEA Fibromyalgia Treatment Market
5.4.1 LAMEA Fibromyalgia Treatment Market by Drug Class
5.4.1.1 LAMEA Anticonvulsants Market by Country
5.4.1.2 LAMEA Antidepressants Market by Country
5.4.1.3 LAMEA Muscle Relaxants Market by Country
5.4.1.4 LAMEA Others Market by Country
5.4.2 LAMEA Fibromyalgia Treatment Market by Distribution Channel
5.4.2.1 LAMEA Drug stores & Retail Pharmacies Market by Country
5.4.2.2 LAMEA Hospital Pharmacies Market by Country
5.4.2.3 LAMEA Online Providers Market by Country
5.4.3 LAMEA Fibromyalgia Treatment Market by Country
5.4.3.1 Brazil Fibromyalgia Treatment Market
5.4.3.1.1 Brazil Fibromyalgia Treatment Market by Drug Class
5.4.3.1.2 Brazil Fibromyalgia Treatment Market by Distribution Channel
5.4.3.2 Argentina Fibromyalgia Treatment Market
5.4.3.2.1 Argentina Fibromyalgia Treatment Market by Drug Class
5.4.3.2.2 Argentina Fibromyalgia Treatment Market by Distribution Channel
5.4.3.3 UAE Fibromyalgia Treatment Market
5.4.3.3.1 UAE Fibromyalgia Treatment Market by Drug Class
5.4.3.3.2 UAE Fibromyalgia Treatment Market by Distribution Channel
5.4.3.4 Saudi Arabia Fibromyalgia Treatment Market
5.4.3.4.1 Saudi Arabia Fibromyalgia Treatment Market by Drug Class
5.4.3.4.2 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel
5.4.3.5 South Africa Fibromyalgia Treatment Market
5.4.3.5.1 South Africa Fibromyalgia Treatment Market by Drug Class
5.4.3.5.2 South Africa Fibromyalgia Treatment Market by Distribution Channel
5.4.3.6 Nigeria Fibromyalgia Treatment Market
5.4.3.6.1 Nigeria Fibromyalgia Treatment Market by Drug Class
5.4.3.6.2 Nigeria Fibromyalgia Treatment Market by Distribution Channel
5.4.3.7 Rest of LAMEA Fibromyalgia Treatment Market
5.4.3.7.1 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class
5.4.3.7.2 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 AbbVie, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Novartis AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Eli Lilly And Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Amneal Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.7 Zydus Lifesciences Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.8 Lupin Limited
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Recent strategies and developments:
6.8.3.1 Trials and Approvals:
6.9 Viatris, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
6.10. Sun Pharmaceutical Industries Ltd.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses

TABLE 1 Global Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 2 Global Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 3 Global Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 Global Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 Global Anticonvulsants Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Anticonvulsants Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Antidepressants Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Antidepressants Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Muscle Relaxants Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Muscle Relaxants Market by Region, 2023 - 2030, USD Million
TABLE 11 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 13 Global Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 Global Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 15 Global Drug stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Drug stores & Retail Pharmacies Market by Region, 2023 - 2030, USD Million
TABLE 17 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Million
TABLE 19 Global Online Providers Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Online Providers Market by Region, 2023 - 2030, USD Million
TABLE 21 Global Fibromyalgia Treatment Market by Region, 2019 - 2022, USD Million
TABLE 22 Global Fibromyalgia Treatment Market by Region, 2023 - 2030, USD Million
TABLE 23 North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 24 North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 25 North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 26 North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 27 North America Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 North America Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 45 US Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 46 US Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 47 US Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 48 US Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 49 US Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 US Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Canada Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 52 Canada Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 53 Canada Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Canada Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 55 Canada Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 Canada Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 Mexico Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 58 Mexico Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 59 Mexico Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 60 Mexico Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 61 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 Rest of North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 64 Rest of North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 65 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 66 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 67 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 69 Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 70 Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 71 Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 72 Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 73 Europe Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 74 Europe Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 75 Europe Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 76 Europe Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 77 Europe Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 78 Europe Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 79 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 80 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 81 Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Europe Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 84 Europe Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 85 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 86 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 87 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 88 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 89 Europe Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 90 Europe Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 91 Germany Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 92 Germany Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 93 Germany Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 94 Germany Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 95 Germany Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 96 Germany Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 97 UK Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 98 UK Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 99 UK Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 100 UK Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 101 UK Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 102 UK Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 103 France Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 104 France Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 105 France Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 106 France Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 107 France Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 108 France Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 109 Russia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 110 Russia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 111 Russia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 112 Russia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 113 Russia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 114 Russia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 115 Spain Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 116 Spain Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 117 Spain Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 118 Spain Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 119 Spain Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 120 Spain Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 121 Italy Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 122 Italy Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 123 Italy Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 124 Italy Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 125 Italy Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 126 Italy Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 127 Rest of Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 128 Rest of Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 129 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 130 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 131 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 132 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 133 Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 134 Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 135 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 136 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 137 Asia Pacific Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 138 Asia Pacific Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 139 Asia Pacific Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 140 Asia Pacific Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 141 Asia Pacific Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 142 Asia Pacific Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 143 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 144 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 145 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 146 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 147 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 148 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 149 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 150 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 151 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 152 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 153 Asia Pacific Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 154 Asia Pacific Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 155 China Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 156 China Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 157 China Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 158 China Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 159 China Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 160 China Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 161 Japan Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 162 Japan Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 163 Japan Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 164 Japan Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 165 Japan Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 166 Japan Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 167 India Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 168 India Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 169 India Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 170 India Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 171 India Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 172 India Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 173 South Korea Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 174 South Korea Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 175 South Korea Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 176 South Korea Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 177 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 178 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 179 Singapore Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 180 Singapore Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 181 Singapore Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 182 Singapore Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 183 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 184 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 185 Malaysia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 186 Malaysia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 187 Malaysia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 188 Malaysia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 189 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 190 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 191 Rest of Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 192 Rest of Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 193 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 194 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 195 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 196 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 197 LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 198 LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 199 LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 200 LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 201 LAMEA Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 202 LAMEA Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 203 LAMEA Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 204 LAMEA Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 205 LAMEA Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 206 LAMEA Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 207 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 208 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 209 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 210 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 211 LAMEA Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 212 LAMEA Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 213 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 214 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 215 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 216 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 217 LAMEA Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 218 LAMEA Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 219 Brazil Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 220 Brazil Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 221 Brazil Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 222 Brazil Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 223 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 224 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 225 Argentina Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 226 Argentina Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 227 Argentina Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 228 Argentina Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 229 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 230 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 231 UAE Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 232 UAE Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 233 UAE Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 234 UAE Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 235 UAE Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 236 UAE Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 237 Saudi Arabia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 238 Saudi Arabia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 239 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 240 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 241 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 242 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 243 South Africa Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 244 South Africa Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 245 South Africa Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 246 South Africa Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 247 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 248 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 249 Nigeria Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 250 Nigeria Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 251 Nigeria Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 252 Nigeria Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 253 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 254 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 255 Rest of LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 256 Rest of LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 257 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 258 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 259 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 260 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 261 Key Information – Abbott Laboratories
TABLE 262 Key information – AbbVie, Inc.
TABLE 263 Key Information – Novartis AG
TABLE 264 Key Information – Eli Lilly And Company
TABLE 265 Key Information – Amneal Pharmaceuticals, INc.
TABLE 266 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 267 Key Information – Zydus Lifesciences Ltd.
TABLE 268 Key Information – Lupin Limited
TABLE 269 key information – Viatris, Inc.
TABLE 270 Key Information – Sun Pharmaceutical Industries Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Fibromyalgia Treatment Market share by Drug Class, 2022
FIG 3 Global Fibromyalgia Treatment Market share by Drug Class, 2030
FIG 4 Global Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
FIG 5 Global Fibromyalgia Treatment Market share by Distribution Channel, 2022
FIG 6 Global Fibromyalgia Treatment Market share by Distribution Channel, 2030
FIG 7 Global Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Global Fibromyalgia Treatment Market share by Region, 2022
FIG 9 Global Fibromyalgia Treatment Market share by Region, 2030
FIG 10 Global Fibromyalgia Treatment Market by Region, 2019 - 2030, USD Million
FIG 11 Swot analysis: Abbott laboratories